ResearcherUniversity of NamurActive in the last 2 years

Bao‐Lian Su

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8474-0652; OpenAlex author ID A5022972481. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

TriCON: A Carbon-Based Triple-Modal Nanoplatform for Pancreatic Cancer Therapy. Last author DOI 10.1002/advs.202512978 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shengnan Lv · 1 shared paper, 2026 · strength 0.29
- Paper TriCON: A Carbon-Based Triple-Modal Nanoplatform for Pancreatic Cancer Therapy. DOI 10.1002/advs.202512978 ↗
Yan Liu · 1 shared paper, 2026 · strength 0.29
- Paper TriCON: A Carbon-Based Triple-Modal Nanoplatform for Pancreatic Cancer Therapy. DOI 10.1002/advs.202512978 ↗
Feng Wei · 1 shared paper, 2026 · strength 0.29
- Paper TriCON: A Carbon-Based Triple-Modal Nanoplatform for Pancreatic Cancer Therapy. DOI 10.1002/advs.202512978 ↗
Xinyu Peng · 1 shared paper, 2026 · strength 0.29
- Paper TriCON: A Carbon-Based Triple-Modal Nanoplatform for Pancreatic Cancer Therapy. DOI 10.1002/advs.202512978 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.